Natixis Advisors, L.P. Johnson & Johnson Transaction History
Natixis Advisors, L.P.
- $68.5 Billion
- Q3 2025
A detailed history of Natixis Advisors, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,504,636 shares of JNJ stock, worth $300 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
1,504,636
Previous 1,306,987
15.12%
Holding current value
$300 Million
Previous $200 Million
39.74%
% of portfolio
0.41%
Previous 0.32%
Shares
33 transactions
Others Institutions Holding JNJ
# of Institutions
4,817Shares Held
1.73BCall Options Held
20.4MPut Options Held
17.2M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...